<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT921-10599</title>
	</head>
	<body>
		<main>
			<p>920205 FT  05 FEB 92 / Shareholders to sue Upjohn officials OFFICIALS at Upjohn, the Michigan-based pharmaceuticals company, are facing a shareholder lawsuit charging them with concealing information about problems with Halcion, the world's most widely prescribed sleeping pill, writes Karen Zagor in New York. The company, which recently denied a report that it had concealed data about the drug's side-effects from the Food and Drug Administration, said it believed the shareholder claims had no merit and the company would vigorously defend itself. Mr Theodore Cooper, Upjohn's chairman, and eight directors were named in the suit filed in a federal court in New York. News of the suit had little impact on Upjohn's share price. At the close in New York yesterday it had fallen Dollars  1/2 to Dollars 42 1/2 .</p>
		</main>
</body></html>
            